MedPath

An exploratory study on the curative effect of Xia's electrothermal needle in the treatment of chronic atrophic gastritis with intestinal metaplasia

Early Phase 1
Not yet recruiting
Conditions
Chronic atrophic gastritis with intestinal metaplasia
Registration Number
ITMCTR2024000085
Lead Sponsor
Wangjing Hospital, China Academy of Chinese Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Meet the diagnostic criteria of chronic atrophic gastritis with intestinal metaplasia;
(2) Prior to enrollment, electronic gastroscopy and histopathology confirmed atrophy (reduced intrinsic glands) with mild or moderate enterosis (intestinal metaplasia), with or without mild or moderate dysplasia;
(2) Consistent with the TCM diagnosis and syndrome differentiation of chronic atrophic gastritis with intestinal metaplasia;
(3) Gender is not limited, age between 18 and 75 years old;
(4) The patient's informed consent and willingness to accept the appropriate treatment;
(5) Voluntary signing of informed consent.

Exclusion Criteria

(1) autoimmune gastritis;
(2) Patients with other serious complications such as malignant tumors;
(3) Gastric mucosa with high-grade intraepithelial neoplasia or suspected malignant transformation by pathological diagnosis;
(4) Those who are taking aspirin, warfarin and other anticoagulants, or have coagulation disorders;
(5) Patients with serious primary diseases such as heart, brain, liver, kidney, lung and blood system;
(6) Women who are lactating or even pregnant;
(7) Complicated with serious mental illness, unclear description of their own symptoms, unable to cooperate;
(8) Patients who are participating in clinical trials of other drugs.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.